Jamie Dananberg, Chief Medical Officer at Unity Biotechnology, Inc. (UBX), sold 1,016 shares at $2.85 ($3K) on 2022-12-14, disclosed to the SEC on 2022-12-15.
Scheduled sale ($3k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANNX | SELL | 2025-02-20 | $16K | — | Filing → |
| UBX | SELL | 2023-04-03 | $714 | — | Filing → |
| UBX | SELL | 2023-03-15 | $4K | — | Filing → |